Air China (753.hk): Optimism Growing on Airline Stocks

As Moderna reported promising results of its Covid-19 vaccine, optimism is growing on old-economy stocks...

New Highs 4

After Pfizer reported breakthrough in its Covid-19 vaccine last week, Moderna said its mRNA-1273 showed a vaccine efficacy of 94.5% in a phase 3 study. Old-economy stocks, which were the most suffered during the pandemic, are likely to gain more traction amid growing optimism on a rebound in the global economic activity.

Airline stocks could be the most eye catching. Major Chinese airline Air China (753.hk) reported that passenger traffic rose 9.8% on month in October, up for a fifth straight month, and year-on-year decline narrowed to 35.3% from 79.2% in April.

On a daily chart, Air China (753.hk) may have shown a key turnaround after breaking above a long term bearish trend line. Currently, it is moving higher and away from both the 20-day and 50-day moving averages, while the relative strength index has jumped to the 70s. The level at $5.48 might be considered as the key support, while the 1st and 2nd resistance are expected to be located at $6.93 and $7.60 respectively.


Source: GAIN Capital, TradingView

More from Stocks

Disclaimer

This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit cityindex.com.sg for the complete Risk Disclosure Statement.

Important Notice:

Cryptocurrencies are not legal tender currency and trading of derivatives on Cryptocurrencies are currently not covered under any regulatory regime in Singapore. Consequently, investors should be aware they do not have protection under the Securities and Futures Act (Cap. 289). Please ensure that you are fully aware of the risks.